V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192825 | 20124071 | 1.48 | 54 | Palliative (P) | 2020-03-21 | 2020-03-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100240843 |
| 20192829 | 20124072 | null | 145.3 | Palliative (P) | 2018-04-10 | 2018-04-13 | Gemcitabine + Capecitabine | 02 | N | DOCETAXEL | 100686261 |
| 20192831 | 20124073 | 1.59 | 81.3 | null | 2022-04-26 | 2022-04-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100509156 |
| 20192832 | 20124074 | 1.61 | 77.8 | Adjuvant (A) | 2018-05-10 | 2018-05-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101541746 |
| 20192834 | 20124075 | 1.92 | 65.4 | Palliative (P) | 2018-08-26 | 2018-09-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100223283 |
| 20192836 | 20124076 | 1.84 | 68.5 | null | 2017-07-21 | 2017-07-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100059502 |
| 20192839 | 20124077 | 1.83 | 66 | null | 2019-10-15 | 2020-01-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100481427 |
| 20192840 | 20124078 | 1.76 | 77.8 | Palliative (P) | 2016-10-31 | 2017-05-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100077054 |
| 20192846 | 20124079 | 1.71 | 77.6 | Palliative (P) | 2016-07-17 | 2016-07-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100125053 |
| 20192849 | 20124080 | 1.91 | 66.8 | Palliative (P) | 2018-12-25 | 2019-05-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100188535 |
| 20192850 | 20124081 | 1.87 | 133.7 | Palliative (P) | 2021-02-08 | 2021-02-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100277684 |
| 20192855 | 20124083 | 1.71 | 53.6 | Palliative (P) | 2017-08-26 | 2017-08-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100299129 |
| 20192858 | 20124084 | 1.69 | 88 | null | 2018-10-05 | 2018-10-15 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101530011 |
| 20192859 | 20124085 | 1.74 | 61.8 | Palliative (P) | 2018-05-26 | 2018-06-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100048517 |
| 20192863 | 20124086 | 1.61 | 71.3 | Palliative (P) | 2022-03-07 | 2022-03-22 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101373419 |
| 20192865 | 20124087 | 1.67 | 71.8 | null | 2016-05-26 | 2016-05-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100507628 |
| 20192869 | 20124088 | 1.67 | 65 | Palliative (P) | 2017-01-19 | 2017-01-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101415449 |
| 20192871 | 20124089 | 1.67 | null | Palliative (P) | 2017-07-05 | 2017-08-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101715910 |
| 20192872 | 20124090 | 1.74 | 104.1 | Palliative (P) | 2017-07-15 | 2017-07-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100260318 |
| 20192873 | 20124091 | 1.72 | 67.8 | null | 2018-05-31 | 2018-06-16 | Docetaxel | 02 | null | DOCETAXEL | 100826997 |
| 20192879 | 20124092 | 1.7 | 64 | Palliative (P) | 2017-12-31 | 2018-01-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101313624 |
| 20192889 | 20124093 | 1.6 | 62 | Curative (C) | 2018-07-25 | 2018-08-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100919093 |
| 20192891 | 20124094 | 1.55 | 59.7 | null | 2020-03-31 | 2020-03-31 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101735137 |
| 20192895 | 20124095 | 1.85 | 66 | Palliative (P) | null | 2019-02-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100321913 |
| 20192899 | 20124096 | 1.77 | 67 | Palliative (P) | 2020-05-24 | 2020-12-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101215039 |
| 20192900 | 20124097 | 1.83 | 49.5 | Palliative (P) | 2018-06-22 | 2018-06-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101458271 |
| 20192902 | 20124098 | 1.82 | 67.95 | Palliative (P) | 2016-12-12 | 2016-12-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101433163 |
| 20192903 | 20124099 | 1.7 | 67.8 | Palliative (P) | 2017-11-22 | 2017-11-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101296919 |
| 20192906 | 20124100 | 1.69 | 63.8 | Palliative (P) | 2016-05-18 | 2016-09-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100727415 |
| 20192907 | 20124101 | 1.93 | 63 | Palliative (P) | 2021-09-27 | 2021-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101530306 |
| 20192908 | 20124102 | 1.67 | 95.95 | Palliative (P) | 2016-06-22 | 2016-07-15 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100367881 |
| 20192913 | 20124103 | 1.61 | 66.5 | null | 2019-09-04 | 2020-02-16 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101689609 |
| 20192915 | 20124104 | 1.68 | 64 | Adjuvant (A) | 2015-07-20 | 2015-07-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100115020 |
| 20192917 | 20124105 | 1.54 | 60 | Palliative (P) | 2019-02-06 | 2019-02-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100850394 |
| 20192920 | 20124106 | 1.66 | 58.8 | Palliative (P) | 2017-11-29 | 2018-01-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100237385 |
| 20192923 | 20124107 | 1.53 | 88 | Palliative (P) | 2019-11-30 | 2019-12-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101479729 |
| 20192930 | 20124108 | 1.84 | 70.3 | null | 2018-09-11 | 2018-10-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101173374 |
| 20192935 | 20124109 | 1.75 | 102 | Palliative (P) | 2017-03-24 | 2017-04-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101610482 |
| 20192938 | 20124110 | 1.75 | 102 | Palliative (P) | 2018-03-26 | 2018-04-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100285354 |
| 20192940 | 20124111 | 1.63 | 52.2 | Palliative (P) | 2018-06-24 | 2018-07-12 | Docetaxel | 02 | N | DOCETAXEL | 101808580 |
| 20192942 | 20124112 | 1.84 | 58 | Palliative (P) | 2016-03-05 | 2016-04-01 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100176299 |
| 20192947 | 20124113 | 1.8 | 70 | Palliative (P) | 2017-02-20 | 2017-03-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100933698 |
| 20192956 | 20124114 | 1.53 | 50.1 | Palliative (P) | 2019-08-30 | 2019-09-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100151692 |
| 20192960 | 20124115 | 1.61 | 81.15 | Adjuvant (A) | 2018-05-11 | 2018-05-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101207808 |
| 20192965 | 20124116 | 1.93 | 89.2 | Palliative (P) | 2017-03-24 | 2017-03-31 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101445301 |
| 20192969 | 20124117 | 1.5 | 39.9 | Palliative (P) | 2019-05-10 | 2019-05-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101212753 |
| 20192973 | 20124118 | 1.85 | 72 | null | 2017-07-06 | 2017-07-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100184571 |
| 20192975 | 20124119 | 1.52 | 75.1 | Palliative (P) | 2016-11-16 | 2016-12-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100680133 |
| 20192978 | 20124120 | 1.66 | 77.8 | 02 | 2016-12-05 | 2016-12-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101017036 |
| 20192989 | 20124121 | 1.9 | 105 | Palliative (P) | 2018-02-03 | 2018-06-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101714537 |